Cancer Therapy News and Research

RSS

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Researchers develop two-pronged approach to personalize breast cancer treatment

The goal of cancer therapy is to destroy the tumor or stop it from growing and spreading to other parts of the body.

28 Mar 2017

Public-private collaboration to develop more accurate methods of tracking cancer progression

Columbia University Medical Center and NewYork-Presbyterian, in coordination with the Foundation for the National Institutes of Health Biomarkers Consortium, is launching a three-year research collaboration to develop new methods for analyzing digital images that track a patient's response to cancer therapy.

28 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

New imaging project for new applications in cancer diagnostics

Innovative medical device contractor ITL Group has partnered up with King’s College London (KCL) to develop a ground-breaking cancer imaging project.

From Vitl Life Science Solutions 27 Mar 2017

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.

27 Mar 2017

Virtual environment education decreases anxiety before prostate cancer treatment

Radiation therapists and physicians know that education can reduce anxiety before radiation treatment but lack a standardized tool. In an effort to solve this problem, a multidisciplinary team from Jefferson College of Health Professions and Sidney Kimmel Cancer Center at Thomas Jefferson University conducted a pilot study to see if a virtual environment education program could reduce some of the anxiety their patients face.

25 Mar 2017

Study finds increased body fat in childhood brain cancer survivors

McMaster University researchers have discovered that while survivors of childhood brain tumours have a similar Body Mass Index (BMI) to healthy children with no cancer, they have more fat tissue overall, and especially around the abdomen.

24 Mar 2017

Berkeley researchers search for cancer clues in sample of blood

One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring a panel of cancer proteins in rare, individual tumor cells that float in the blood.

24 Mar 2017

Study identifies potential risks for mothers who are cancer survivors

For young women facing a new cancer diagnosis, fertility preservation can be an important consideration in treatment planning. Now a University of North Carolina Lineberger Comprehensive Cancer Center-led study has identified potential risks for mothers who are cancer survivors -- risks for their newborns' health.

23 Mar 2017

Genome sequencing approach opens door to therapy options for rare, neglected cancers

An international team of scientists led by the Icahn School of Medicine at Mount Sinai and UConn School of Medicine have reported the results of a genome sequencing study for an extremely rare form of cancer.

23 Mar 2017

Researchers identify odorant troenan that can inhibit colorectal cancer growth

Growth of colorectal cancer cells can be inhibited with the odorant troenan. This is reported by the research team headed by Prof Dr Dr Dr habil. Hanns Hatt and Dr Lea Weber from Ruhr-Universität Bochum in the journal "PLOS One".

23 Mar 2017

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Dana-Farber Cancer Institute and Lifespan leadership are creating a strategic alliance to advance cancer treatment and research.

22 Mar 2017

Chemists develop biosafe luminescent nanoparticles for imaging tumors and blood vessels

Chemists from Russia and Switzerland created biosafe luminescent nanoparticles for imaging tumors and blood vessels damaged by heart attack or stroke.

21 Mar 2017

MIT researchers devise new strategy to make tumor cells more susceptible to cancer treatment

MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs.

20 Mar 2017

Genetic mutations underlying treatment resistance in NSCLC more dynamic than previously thought

The genetic mutations underlying treatment resistance in non-small cell lung cancer (NSCLC) are more complex and dynamic than previously thought.

17 Mar 2017

Combination approach holds potential for treating lung cancer patients

An emerging approach for cancer treatment seeks to combine radiation therapy with immune checkpoint inhibitors to more effectively control tumors in the chest with an acceptable risk of severe treatment-related side effects.

17 Mar 2017

TSRI researchers develop novel drug delivery method for treating cancers

Scientists from the Florida campus of The Scripps Research Institute have developed a new drug delivery method that produces strong results in treating cancers in animal models, including some hard-to-treat solid and liquid tumors.

16 Mar 2017

Innovative strategy uses genetically modified viruses to selectively attack tumor cells

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting healthy tissues.

16 Mar 2017

Antibody treats pediatric brain tumors safely and effectively in mice

Five types of pediatric brain cancer were safely and effectively treated in mice by an antibody that causes immune cells to engulf and eat tumors without hurting healthy brain cells, according to a new study by researchers at the Stanford University School of Medicine.

15 Mar 2017

Cancer Therapy News and Research

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

Researchers develop two-pronged approach to personalize breast cancer treatment

Public-private collaboration to develop more accurate methods of tracking cancer progression

FDA approves new maintenance therapy for recurrent cancers

New imaging project for new applications in cancer diagnostics

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Virtual environment education decreases anxiety before prostate cancer treatment

Study finds increased body fat in childhood brain cancer survivors

Berkeley researchers search for cancer clues in sample of blood

Study identifies potential risks for mothers who are cancer survivors

Genome sequencing approach opens door to therapy options for rare, neglected cancers

Researchers identify odorant troenan that can inhibit colorectal cancer growth

Dana-Farber and Lifespan enter into strategic alliance to advance cancer treatment and research

Chemists develop biosafe luminescent nanoparticles for imaging tumors and blood vessels

MIT researchers devise new strategy to make tumor cells more susceptible to cancer treatment

Genetic mutations underlying treatment resistance in NSCLC more dynamic than previously thought

Combination approach holds potential for treating lung cancer patients

TSRI researchers develop novel drug delivery method for treating cancers

Innovative strategy uses genetically modified viruses to selectively attack tumor cells

Antibody treats pediatric brain tumors safely and effectively in mice

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News